We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPS20 is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the pTPM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (pTPM) was examined. The best expression cut-off refers the pTPM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average pTPM
5373.0
Number of samples
349
Samples
Sample
Description
pTPM
TCGA-13-1499-01A
56 years, female, white, stage:Stage IIIC, alive, 3500 days
110373.0
TCGA-13-0762-01A
65 years, female, white, stage:Stage IIIC, alive, 3400 days
30227.4
TCGA-30-1853-01A
58 years, female, white, stage:Stage IIIC, dead, 1103 days
18964.2
TCGA-04-1542-01A
52 years, female, white, stage:Stage IIIB, dead, 2561 days
16770.8
TCGA-10-0927-01A
65 years, female, stage:Stage IIIC, dead, 2490 days
16433.0
TCGA-29-1703-01A
56 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
14652.5
TCGA-24-1544-01A
71 years, female, black or african american, stage:Stage IIIC, dead, 820 days
14463.0
TCGA-13-0888-01A
78 years, female, white, stage:Stage IIIC, dead, 2811 days
12491.4
TCGA-13-1409-01A
73 years, female, white, stage:Stage IIIC, dead, 1742 days
12339.0
TCGA-10-0928-01A
71 years, female, white, stage:Stage IIIC, dead, 563 days
11469.1
TCGA-10-0938-01A
80 years, female, white, stage:Stage IIIC, dead, 636 days
11418.6
TCGA-13-1489-01A
70 years, female, white, stage:Stage IIIC, dead, 2553 days
11240.9
TCGA-57-1583-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 346 days
10959.0
TCGA-23-1028-01A
43 years, female, white, stage:Stage IIIC, alive, 1503 days
10953.2
TCGA-13-1404-01A
48 years, female, white, stage:Stage IIIC, alive, 2469 days
10892.8
TCGA-25-1317-01A
66 years, female, white, stage:Stage IIIC, dead, 61 days
10842.0
TCGA-04-1347-01A
81 years, female, white, stage:Stage IV, alive, 1919 days
10785.1
TCGA-13-0920-01A
65 years, female, white, stage:Stage IIIC, dead, 1484 days
10347.6
TCGA-04-1341-01A
85 years, female, white, stage:'--, alive, 33 days
10270.1
TCGA-04-1350-01A
46 years, female, white, stage:Stage IIIC, dead, 1946 days
10107.8
TCGA-23-1022-01A
67 years, female, white, stage:Stage IIIC, dead, 1511 days
9477.7
TCGA-30-1857-01A
64 years, female, white, stage:Stage IV, dead, 8 days
9424.9
TCGA-59-2355-01A
58 years, female, white, stage:Stage IV, dead, 65 days
9306.5
TCGA-25-1634-01A
75 years, female, white, stage:Stage IIIC, dead, 1091 days
9305.1
TCGA-61-1721-01A
38 years, female, white, stage:Stage IV, alive, 338 days
9192.0
TCGA-13-0725-01A
44 years, female, white, stage:Stage IIIC, dead, 377 days
9101.8
TCGA-13-1487-01A
74 years, female, white, stage:Stage IV, dead, 681 days
9082.3
TCGA-23-1116-01A
83 years, female, white, stage:Stage IIIC, dead, 592 days
9073.9
TCGA-13-1510-01A
62 years, female, white, stage:Stage IIIC, dead, 1359 days
9029.6
TCGA-25-1316-01A
55 years, female, white, stage:Stage IIIC, dead, 1279 days
8737.1
TCGA-29-2425-01A
60 years, female, white, stage:Stage IIIC, alive, 1977 days
8607.1
TCGA-24-0968-01A
59 years, female, white, stage:Stage IIIC, dead, 598 days
8493.8
TCGA-13-0724-01A
72 years, female, white, stage:Stage IV, dead, 83 days
8485.7
TCGA-23-1119-01A
64 years, female, white, stage:Stage IIIC, alive, 3953 days
8425.7
TCGA-13-0804-01A
73 years, female, white, stage:Stage IIIC, dead, 1073 days
8268.4
TCGA-13-1501-01A
50 years, female, white, stage:Stage IV, dead, 1314 days
8002.0
TCGA-20-0991-01A
78 years, female, white, stage:Stage IIB, alive, 797 days
7990.6
TCGA-24-2038-01A
68 years, female, white, stage:Stage IIIA, dead, 1354 days
7978.4
TCGA-61-1728-01A
59 years, female, white, stage:Stage IV, alive, 848 days
7851.2
TCGA-13-1509-01A
64 years, female, white, stage:Stage IV, alive, 2438 days
7818.7
TCGA-29-2414-01A
75 years, female, white, stage:Stage IIIC, dead, 2621 days
7737.2
TCGA-24-1604-01A
66 years, female, white, stage:Stage IIIC, dead, 2688 days
7716.3
TCGA-10-0937-01A
44 years, female, white, stage:Stage IIIC, dead, 608 days
7702.6
TCGA-13-0765-01A
50 years, female, white, stage:Stage IIIC, dead, 1389 days
7677.6
TCGA-29-1783-01A
58 years, female, white, stage:Stage IIIC, alive, 220 days
7551.6
TCGA-23-1118-01A
45 years, female, white, stage:Stage IIIC, alive, 2616 days
7482.5
TCGA-13-1488-01A
59 years, female, white, stage:Stage IV, dead, 2154 days
7453.1
TCGA-23-1113-01A
48 years, female, white, stage:Stage IV, dead, 949 days
7420.8
TCGA-13-2060-01A
51 years, female, white, stage:Stage IV, alive, 2369 days
7383.7
TCGA-04-1519-01A
48 years, female, stage:Stage IIIC, alive, 24 days
7370.6
TCGA-24-1413-01A
51 years, female, white, stage:Stage IIIC, alive, 192 days
7319.9
TCGA-59-2363-01A
40 years, female, asian, stage:Stage IIIA, alive, 165 days
7290.1
TCGA-30-1891-01A
61 years, female, white, stage:Stage IIIC, dead, 914 days
7288.2
TCGA-20-1686-01A
75 years, female, white, stage:Stage IIIC, alive, 89 days
7257.9
TCGA-24-0979-01A
53 years, female, white, stage:Stage IV, dead, 1264 days
7256.0
TCGA-24-1923-01A
51 years, female, white, stage:Stage IIIC, dead, 690 days
7246.8
TCGA-09-2048-01A
63 years, female, white, stage:Stage IIIC, dead, 138 days
7128.4
TCGA-13-1477-01A
49 years, female, white, stage:Stage IV, dead, 1662 days
7119.9
TCGA-13-0766-01A
42 years, female, white, stage:Stage IIIC, dead, 1725 days
7101.4
TCGA-23-1109-01A
62 years, female, white, stage:Stage IIIC, dead, 1562 days
7072.4
TCGA-24-1105-01A
36 years, female, white, stage:Stage IIIC, dead, 1442 days
7065.3
TCGA-30-1714-01A
68 years, female, white, stage:Stage IV, dead, 1158 days
6984.3
TCGA-24-1464-01A
70 years, female, white, stage:Stage IIIC, dead, 379 days
6839.7
TCGA-09-0367-01A
67 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
6817.2
TCGA-09-1670-01A
57 years, female, white, stage:Stage IIIA, alive, 547 days
6804.4
TCGA-20-1687-01A
46 years, female, white, stage:Stage IV, alive, 81 days
6777.9
TCGA-61-2002-01A
46 years, female, white, stage:Stage IIIC, alive, 547 days
6763.1
TCGA-10-0931-01A
44 years, female, white, stage:Stage IIIC, dead, 1000 days
6705.5
TCGA-29-1777-01A
47 years, female, white, stage:Stage IIIC, alive, 374 days
6697.7
TCGA-OY-A56Q-01A
78 years, female, black or african american, stage:Stage IIA, alive, 576 days
6692.6
TCGA-25-1313-01A
62 years, female, white, stage:Stage IV, dead, 820 days
6678.1
TCGA-61-1998-01A
48 years, female, white, stage:Stage IIIC, alive, 168 days
6665.9
TCGA-04-1338-01A
78 years, female, white, stage:Stage IIIC, alive, 1418 days
6663.6
TCGA-36-1580-01A
82 years, female, stage:Stage IIIC, dead, 737 days
6635.9
TCGA-13-0923-01A
74 years, female, white, stage:Stage IIIC, alive, 2547 days
6627.3
TCGA-24-1850-01A
72 years, female, white, stage:Stage IIIC, alive, 168 days
6559.3
TCGA-24-0982-01A
77 years, female, white, stage:Stage IIIC, dead, 679 days
6549.3
TCGA-24-2035-01A
65 years, female, white, stage:Stage IIIC, dead, 857 days
6547.6
TCGA-24-1426-01A
43 years, female, white, stage:Stage IIIC, alive, 163 days
6515.9
TCGA-29-1766-01A
74 years, female, white, stage:Stage IIIC, dead, 1199 days
6490.0
TCGA-24-0966-01A
78 years, female, black or african american, stage:Stage IIIC, alive, 232 days
6447.6
TCGA-25-1632-01A
68 years, female, white, stage:Stage IV, dead, 1799 days
6409.8
TCGA-04-1343-01A
72 years, female, white, stage:Stage IV, dead, 361 days
6371.8
TCGA-20-1682-01A
56 years, female, white, stage:Stage IIIC, alive, 837 days
6368.6
TCGA-13-0714-01A
55 years, female, white, stage:Stage IV, dead, 189 days
6364.3
TCGA-04-1332-01A
70 years, female, white, stage:Stage IIIC, dead, 1247 days
6357.8
TCGA-24-1416-01A
34 years, female, white, stage:Stage IV, alive, 194 days
6173.3
TCGA-61-1914-01A
65 years, female, stage:Stage IIIC, alive, 1722 days
6163.7
TCGA-30-1892-01A
52 years, female, white, stage:Stage IIIC, dead, 1484 days
6093.2
TCGA-13-1498-01A
73 years, female, white, stage:Stage IIIC, dead, 2012 days
6002.9
TCGA-29-1691-01A
51 years, female, white, stage:Stage IIIC, dead, 1470 days
5940.6
TCGA-25-1877-01A
81 years, female, white, stage:Stage IIIC, dead, 730 days
5931.2
TCGA-36-1571-01A
53 years, female, white, stage:Stage IIIB, dead, 695 days
5931.0
TCGA-23-1024-01A
52 years, female, white, stage:Stage IV, alive, 468 days
5919.3
TCGA-24-1550-01A
49 years, female, white, stage:Stage IIIC, dead, 1249 days
5856.3
TCGA-24-1422-01A
82 years, female, black or african american, stage:Stage IIIC, dead, 23 days
5812.6
TCGA-04-1356-01A
62 years, female, white, stage:Stage IIC, dead, 1499 days
5809.4
TCGA-29-1768-01A
50 years, female, white, stage:Stage IV, dead, 952 days
5798.3
TCGA-25-1627-01A
73 years, female, white, stage:Stage IIIC, dead, 394 days
5787.3
TCGA-29-1769-01A
40 years, female, white, stage:Stage IIIC, alive, 699 days
5777.3
TCGA-24-2281-01A
68 years, female, white, stage:Stage IIA, alive, 1357 days
5772.7
TCGA-24-1553-01A
53 years, female, white, stage:Stage IIIB, dead, 1767 days
5767.7
TCGA-13-0886-01A
67 years, female, white, stage:Stage IIIC, alive, 4665 days
5746.5
TCGA-61-2101-01A
55 years, female, white, stage:Stage IIIC, dead, 1688 days
5738.8
TCGA-23-1107-01A
59 years, female, white, stage:Stage IV, dead, 9 days
5719.2
TCGA-23-1030-01A
64 years, female, white, stage:Stage IIIC, alive, 886 days
5694.7
TCGA-13-1505-01A
63 years, female, white, stage:Stage IIIC, alive, 1998 days
5688.2
TCGA-13-0924-01A
45 years, female, white, stage:Stage IV, alive, 2614 days
5680.0
TCGA-23-1111-01A
63 years, female, white, stage:Stage IIIC, alive, 98 days
5669.7
TCGA-04-1365-01A
87 years, female, white, stage:Stage IIIB, alive, 947 days
5635.9
TCGA-61-1919-01A
58 years, female, white, stage:Stage IIIC, dead, 1161 days
5614.0
TCGA-04-1362-01A
59 years, female, white, stage:Stage IIC, dead, 1348 days
5598.5
TCGA-25-2393-01A
81 years, female, white, stage:Stage IIIC, dead, 1157 days
5589.9
TCGA-13-1408-01A
59 years, female, white, stage:Stage IIIC, dead, 1680 days
5569.4
TCGA-23-1110-01A
42 years, female, white, stage:Stage IIIC, alive, 1658 days
5566.5
TCGA-13-0911-01A
55 years, female, white, stage:Stage IV, dead, 1355 days
5560.8
TCGA-13-0885-01A
70 years, female, white, stage:Stage IIIC, alive, 3388 days
5534.6
TCGA-31-1944-01A
47 years, female, white, stage:Stage IIIC, alive, 1386 days
5531.5
TCGA-04-1364-01A
61 years, female, white, stage:Stage IIIC, dead, 1024 days
5526.1
TCGA-13-0891-01A
73 years, female, white, stage:Stage IV, dead, 3128 days
5504.0
TCGA-29-1778-01A
77 years, female, white, stage:Stage IIIC, alive, 454 days
5481.1
TCGA-24-1471-01A
60 years, female, white, stage:Stage IIIC, alive, 36 days
5426.0
TCGA-13-1485-01A
48 years, female, white, stage:Stage IV, dead, 629 days
5419.9
TCGA-13-0726-01A
55 years, female, white, stage:Stage IIIC, dead, 949 days
5404.9
TCGA-13-1483-01A
61 years, female, white, stage:Stage IIIC, dead, 895 days
5345.8
TCGA-13-0795-01A
66 years, female, white, stage:Stage IIIC, dead, 619 days
5312.2
TCGA-04-1655-01A
49 years, female, white, stage:Stage IIIB, dead, 1380 days
5285.5
TCGA-24-2024-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
5262.0
TCGA-25-1328-01A
38 years, female, white, stage:Stage IIIC, dead, 2009 days
5207.7
TCGA-29-1696-01A
43 years, female, white, stage:Stage IIIC, dead, 1032 days
5206.3
TCGA-09-1666-01A
57 years, female, white, stage:Stage IIIC, alive, 1752 days
5176.2
TCGA-29-2427-01A
60 years, female, white, stage:Stage IIIC, alive, 1900 days
5159.8
TCGA-61-2009-01A
65 years, female, white, stage:Stage IIIC, alive, 1212 days
5109.2
TCGA-24-1430-01A
68 years, female, white, stage:Stage IIIC, dead, 863 days
5092.7
TCGA-13-1411-01A
81 years, female, white, stage:Stage IIIC, dead, 531 days
5091.7
TCGA-23-1027-01A
48 years, female, white, stage:Stage IIIC, dead, 976 days
5059.9
TCGA-24-1562-01A
67 years, female, white, stage:Stage IIIC, dead, 1384 days
5034.9
TCGA-29-1690-01A
66 years, female, white, stage:Stage IIIC, dead, 1448 days
5032.0
TCGA-61-1725-01A
40 years, female, white, stage:Stage IIIC, alive, 956 days
5012.4
TCGA-04-1530-01A
68 years, female, white, stage:Stage IIIC, dead, 3622 days
4973.1
TCGA-59-2351-01A
51 years, female, white, stage:Stage IIIC, alive, 3532 days
4947.9
TCGA-24-2298-01A
55 years, female, white, stage:Stage IIIC, dead, 1620 days
4894.5
TCGA-24-2267-01A
58 years, female, white, stage:Stage IIB, dead, 1446 days
4888.5
TCGA-13-1506-01A
45 years, female, white, stage:Stage IIIC, dead, 1039 days
4879.9
TCGA-24-2027-01A
51 years, female, white, stage:Stage IV, dead, 3337 days
4850.0
TCGA-36-1577-01A
43 years, female, asian, stage:Stage IIC, alive, 783 days
4847.1
TCGA-57-1584-01A
47 years, female, white, stage:Stage IIIC, alive, 643 days
4835.4
TCGA-30-1862-01A
65 years, female, white, stage:Stage IV, dead, 186 days
4820.4
TCGA-13-0887-01A
42 years, female, white, stage:Stage IIIC, dead, 2028 days
4782.6
TCGA-29-1761-01A
80 years, female, asian, stage:Stage IIIC, dead, 528 days
4749.0
TCGA-13-1496-01A
65 years, female, white, stage:Stage IIIC, dead, 129 days
4729.5
TCGA-13-0897-01A
54 years, female, white, stage:Stage IIIC, dead, 2182 days
4695.6
TCGA-24-1418-01A
68 years, female, white, stage:Stage IIIC, alive, 243 days
4659.4
TCGA-13-0730-01A
71 years, female, white, stage:Stage IIIC, dead, 542 days
4658.0
TCGA-25-1323-01A
72 years, female, white, stage:Stage IIIC, dead, 395 days
4654.9
TCGA-13-1495-01A
60 years, female, white, stage:Stage IIIC, dead, 2749 days
4621.0
TCGA-59-2350-01A
44 years, female, stage:Stage IV, dead, 679 days
4614.4
TCGA-13-1507-01A
77 years, female, white, stage:Stage IIIC, dead, 1993 days
4610.6
TCGA-5X-AA5U-01A
61 years, female, black or african american, stage:Stage IIC, alive, 361 days
4597.1
TCGA-13-0727-01A
71 years, female, white, stage:Stage IIIC, dead, 462 days
4573.7
TCGA-25-1870-01A
59 years, female, white, stage:Stage IIIC, dead, 455 days
4544.7
TCGA-13-1407-01A
51 years, female, white, stage:Stage IIIC, alive, 2534 days
4538.8
TCGA-25-1321-01A
65 years, female, white, stage:Stage IIIC, dead, 1033 days
4527.9
TCGA-04-1651-01A
53 years, female, white, stage:Stage IIIC, dead, 1102 days
4522.4
TCGA-57-1586-01A
66 years, female, white, stage:Stage IIIC, alive, 679 days
4516.7
TCGA-25-1631-01A
73 years, female, white, stage:Stage IIIC, dead, 9 days
4514.5
TCGA-30-1861-01A
74 years, female, white, stage:Stage IIIC, dead, 1058 days
4506.7
TCGA-30-1866-01A
61 years, female, white, stage:Stage IV, dead, 1114 days
4504.7
TCGA-23-2077-01A
45 years, female, white, stage:Stage IIIC, alive, 3525 days
4466.8
TCGA-13-0800-01A
52 years, female, white, stage:Stage IIIC, alive, 2661 days
4447.6
TCGA-13-1511-01A
52 years, female, asian, stage:Stage IV, dead, 1650 days
4444.0
TCGA-25-1312-01A
69 years, female, white, stage:Stage IV, dead, 31 days
4433.6
TCGA-23-1122-01A
53 years, female, white, stage:Stage IIIC, dead, 1189 days
4376.9
TCGA-04-1536-01A
60 years, female, black or african american, stage:Stage IV, dead, 885 days
4369.1
TCGA-13-0883-01A
61 years, female, white, stage:Stage IIIC, dead, 2097 days
4366.8
TCGA-30-1718-01A
44 years, female, white, stage:Stage IIIC, dead, 1579 days
4322.6
TCGA-24-1428-01A
50 years, female, white, stage:Stage IIIC, alive, 529 days
4316.8
TCGA-29-1762-01A
59 years, female, white, stage:Stage IV, dead, 2634 days
4310.6
TCGA-25-2396-01A
71 years, female, white, stage:Stage IIIC, dead, 92 days
4291.3
TCGA-24-2033-01A
87 years, female, white, stage:Stage IIIC, dead, 562 days
4279.3
TCGA-24-1103-01A
50 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
4264.2
TCGA-25-2392-01A
75 years, female, white, stage:Stage IV, dead, 31 days
4240.0
TCGA-10-0933-01A
77 years, female, white, stage:Stage IIIC, dead, 446 days
4232.8
TCGA-61-1995-01A
43 years, female, white, stage:Stage IIIC, alive, 61 days
4231.8
TCGA-09-1669-01A
54 years, female, white, stage:Stage IIIA, alive, 928 days
4226.6
TCGA-23-1023-01A
65 years, female, white, stage:Stage IIIC, alive, 1233 days
4225.2
TCGA-61-2110-01A
56 years, female, white, stage:Stage IIIC, dead, 1354 days
4219.5
TCGA-31-1946-01A
30 years, female, stage:Stage IIIC, alive, 918 days
4216.0
TCGA-04-1361-01A
57 years, female, white, stage:Stage IIIB, alive, 989 days
4212.2
TCGA-04-1331-01A
78 years, female, white, stage:Stage IIIC, dead, 1336 days
4199.2
TCGA-57-1582-01A
50 years, female, white, stage:Stage IIIC, dead, 731 days
4184.4
TCGA-36-1569-01A
52 years, female, white, stage:Stage IIIC, alive, 885 days
4155.8
TCGA-25-2399-01A
80 years, female, white, stage:Stage IIIC, dead, 608 days
4151.8
TCGA-25-1315-01A
50 years, female, white, stage:Stage IIIC, dead, 1583 days
4115.0
TCGA-24-1435-01A
57 years, female, white, stage:Stage IIIC, dead, 1324 days
4112.2
TCGA-29-1701-01A
56 years, female, white, stage:Stage IIIC, dead, 515 days
4095.9
TCGA-09-1673-01A
50 years, female, white, stage:Stage IV, alive, 92 days
4076.6
TCGA-61-2008-01A
40 years, female, asian, stage:Stage IIC, alive, 932 days
4067.0
TCGA-13-1410-01A
57 years, female, white, stage:Stage IV, alive, 2464 days
4022.0
TCGA-25-2409-01A
71 years, female, white, stage:Stage IV, dead, 821 days
3993.9
TCGA-24-1467-01A
51 years, female, white, stage:Stage IIIC, dead, 3224 days
3969.6
TCGA-24-1924-01A
65 years, female, white, stage:Stage IIIC, dead, 919 days
3968.8
TCGA-25-2398-01A
71 years, female, white, stage:Stage IIIC, dead, 1369 days
3965.0
TCGA-24-1552-01A
77 years, female, white, stage:Stage IIIC, dead, 1259 days
3936.3
TCGA-36-1570-01A
49 years, female, white, stage:Stage IIIC, alive, 655 days
3929.7
TCGA-23-2078-01A
66 years, female, white, stage:Stage IIIC, alive, 2661 days
3909.5
TCGA-13-0720-01A
48 years, female, white, stage:Stage IIIC, dead, 1355 days
3906.8
TCGA-61-1737-01A
42 years, female, white, stage:Stage IV, alive, 1364 days
3901.1
TCGA-20-0987-01A
61 years, female, white, stage:Stage IIIC, dead, 701 days
3893.3
TCGA-13-A5FT-01A
67 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
3886.8
TCGA-24-1431-01A
67 years, female, white, stage:Stage IIIC, dead, 583 days
3885.1
TCGA-24-1845-01A
42 years, female, white, stage:Stage IIIC, alive, 116 days
3881.4
TCGA-09-1662-01A
58 years, female, white, stage:Stage IV, dead, 2717 days
3875.9
TCGA-61-2092-01A
57 years, female, white, stage:Stage IIIC, alive, 1573 days
3836.3
TCGA-24-1423-01A
61 years, female, white, stage:Stage IIIC, alive, 190 days
3823.5
TCGA-09-0369-01A
56 years, female, white, stage:Stage IIIC, dead, 1082 days
3822.4
TCGA-24-1563-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
3818.0
TCGA-61-1738-01A
60 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
3811.2
TCGA-24-1546-01A
46 years, female, white, stage:Stage IIIC, dead, 1955 days
3799.1
TCGA-29-1695-01A
62 years, female, white, stage:Stage IIIC, dead, 1229 days
3796.1
TCGA-31-1956-01A
60 years, female, white, stage:Stage IIIB, alive, 1342 days
3773.6
TCGA-25-1326-01A
61 years, female, white, stage:Stage IIIC, dead, 1249 days
3734.9
TCGA-13-1497-01A
47 years, female, white, stage:Stage IIIC, alive, 3871 days
3732.7
TCGA-24-2020-01A
67 years, female, white, stage:Stage IIIC, dead, 4624 days
3728.9
TCGA-09-2054-01A
58 years, female, black or african american, stage:Stage IIIC, dead, 637 days
3720.2
TCGA-25-1630-01A
73 years, female, white, stage:Stage IIIC, dead, 1162 days
3719.0
TCGA-29-1763-01A
43 years, female, black or african american, stage:Stage IIC, alive, 2032 days
3687.8
TCGA-13-1512-01A
49 years, female, white, stage:Stage IIIC, alive, 442 days
3637.5
TCGA-24-1560-01A
51 years, female, white, stage:Stage IIIC, dead, 1341 days
3632.6
TCGA-61-2097-01A
71 years, female, white, stage:Stage IIC, alive, 1844 days
3619.9
TCGA-23-2084-01A
45 years, female, white, stage:Stage IV, dead, 1516 days
3617.1
TCGA-23-1120-01A
60 years, female, white, stage:Stage IIIC, alive, 130 days
3585.4
TCGA-29-1784-01A
55 years, female, white, stage:Stage IIIC, alive, 163 days
3578.3
TCGA-29-1688-01A
39 years, female, white, stage:Stage IIIC, dead, 2400 days
3575.4
TCGA-24-1425-01A
45 years, female, white, stage:Stage IIIC, alive, 181 days
3571.3
TCGA-61-2000-01A
67 years, female, white, stage:Stage IIIC, alive, 441 days
3570.4
TCGA-36-1576-01A
76 years, female, stage:Stage IIIC, alive, 915 days
3552.0
TCGA-24-1616-01A
56 years, female, white, stage:Stage IIIC, dead, 1163 days
3550.8
TCGA-61-2109-01A
40 years, female, white, stage:Stage IIIC, dead, 629 days
3546.9
TCGA-25-1628-01A
67 years, female, white, stage:Stage IIIC, dead, 627 days
3532.8
TCGA-25-2401-01A
64 years, female, white, stage:Stage IIIC, dead, 90 days
3527.4
TCGA-24-1469-01A
71 years, female, white, stage:Stage IIIC, alive, 277 days
3519.4
TCGA-61-1911-01A
55 years, female, white, stage:Stage IIA, alive, 1293 days
3516.0
TCGA-29-1776-01A
63 years, female, black or african american, stage:Stage IIIC, alive, 360 days
3508.1
TCGA-24-1417-01A
54 years, female, white, stage:Stage IV, alive, 238 days
3502.4
TCGA-09-0364-01A
80 years, female, white, stage:Stage IIC, dead, 887 days
3495.8
TCGA-24-2023-01A
54 years, female, white, stage:Stage IIIA, dead, 1364 days
3485.3
TCGA-61-2003-01A
53 years, female, white, stage:Stage IIIC, alive, 122 days
3473.9
TCGA-59-2352-01A
78 years, female, white, stage:Stage IIIC, dead, 286 days
3472.8
TCGA-24-1567-01A
54 years, female, white, stage:Stage IIIB, dead, 524 days
3456.9
TCGA-29-1694-01A
45 years, female, white, stage:Stage IIIC, dead, 1187 days
3412.1
TCGA-30-1860-01A
58 years, female, white, stage:Stage IIIC, dead, 1366 days
3398.8
TCGA-24-1434-01A
59 years, female, white, stage:Stage IIIC, dead, 568 days
3385.8
TCGA-24-1846-01A
45 years, female, stage:Stage IIIC, alive, 133 days
3350.2
TCGA-61-2111-01A
61 years, female, white, stage:Stage IV, alive, 3825 days
3344.1
TCGA-29-1705-01A
47 years, female, white, stage:Stage IIIC, dead, 555 days
3335.5
TCGA-29-1785-01A
55 years, female, white, stage:Stage IIIC, dead, 1104 days
3316.7
TCGA-13-0916-01A
49 years, female, white, stage:Stage IIIC, alive, 1785 days
3316.7
TCGA-61-1918-01A
45 years, female, white, stage:Stage IV, dead, 479 days
3316.4
TCGA-61-1741-01A
76 years, female, white, stage:Stage IIIB, dead, 1024 days
3291.3
TCGA-61-2098-01A
62 years, female, white, stage:Stage IIIC, alive, 1993 days
3262.9
TCGA-59-2354-01A
63 years, female, white, stage:Stage IIIC, dead, 1046 days
3257.8
TCGA-24-1474-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 676 days
3246.7
TCGA-25-1318-01A
54 years, female, white, stage:Stage IIIC, dead, 1064 days
3241.9
TCGA-24-2290-01A
56 years, female, white, stage:Stage IIIC, dead, 1102 days
3210.6
TCGA-25-1329-01A
76 years, female, white, stage:Stage IIIC, dead, 457 days
3205.9
TCGA-24-2280-01A
74 years, female, white, stage:Stage IIIC, alive, 2143 days
3201.7
TCGA-04-1648-01A
57 years, female, white, stage:Stage IIIC, dead, 871 days
3198.1
TCGA-24-1419-01A
62 years, female, white, stage:Stage IIIC, alive, 239 days
3181.4
TCGA-23-1809-01A
63 years, female, white, stage:Stage IIC, alive, 16 days
3181.1
TCGA-29-1770-01A
54 years, female, white, stage:Stage IIIC, alive, 741 days
3170.5
TCGA-24-1842-01A
49 years, female, white, stage:Stage IIIC, alive, 253 days
3158.7
TCGA-25-1322-01A
62 years, female, white, stage:Stage IV, dead, 91 days
3158.7
TCGA-WR-A838-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 304 days
3140.6
TCGA-29-1697-01A
62 years, female, white, stage:Stage IIIC, dead, 949 days
3117.9
TCGA-29-A5NZ-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
3112.5
TCGA-61-1910-01A
56 years, female, white, stage:Stage IIC, alive, 1127 days
3096.4
TCGA-13-0797-01A
49 years, female, white, stage:Stage IIIC, alive, 2121 days
3061.8
TCGA-59-A5PD-01A
55 years, female, black or african american, stage:Stage IC, dead, 624 days
3053.6
TCGA-13-1492-01A
66 years, female, white, stage:Stage IIIC, dead, 3819 days
3053.2
TCGA-13-0768-01A
73 years, female, white, stage:Stage IIIC, dead, 1784 days
3038.2
TCGA-13-1405-01A
49 years, female, white, stage:Stage IV, dead, 868 days
3008.0
TCGA-13-0906-01A
50 years, female, white, stage:Stage IIIC, alive, 3619 days
2995.5
TCGA-23-1123-01A
59 years, female, white, stage:Stage IIIC, dead, 1018 days
2986.4
TCGA-VG-A8LO-01A
55 years, female, black or african american, stage:Stage IV, dead, 24 days
2980.1
TCGA-57-1585-01A
57 years, female, white, stage:Stage IIIC, dead, 53 days
2969.2
TCGA-61-1900-01A
51 years, female, black or african american, stage:Stage IIIB, alive, 176 days
2931.7
TCGA-31-1950-01A
76 years, female, white, stage:Stage IIIC, alive, 571 days
2925.0
TCGA-13-1403-01A
48 years, female, white, stage:Stage IIIC, dead, 2345 days
2890.8
TCGA-24-1558-01A
73 years, female, white, stage:Stage IIIC, dead, 594 days
2862.3
TCGA-24-1930-01A
53 years, female, white, stage:Stage IIIC, dead, 2467 days
2858.3
TCGA-24-1549-01A
58 years, female, white, stage:Stage IIIB, dead, 1721 days
2827.2
TCGA-25-1623-01A
71 years, female, white, stage:Stage IV, dead, 565 days
2822.3
TCGA-61-1907-01A
63 years, female, white, stage:Stage IIIC, alive, 952 days
2817.9
TCGA-24-2293-01A
47 years, female, white, stage:'--, dead, 506 days
2809.9
TCGA-24-1551-01A
53 years, female, white, stage:Stage IIIC, dead, 1579 days
2787.0
TCGA-24-1104-01A
56 years, female, white, stage:Stage IV, dead, 1933 days
2786.1
TCGA-24-2289-01A
68 years, female, white, stage:Stage IV, dead, 2049 days
2768.8
TCGA-31-1951-01A
58 years, female, white, stage:Stage IIIC, alive, 684 days
2762.0
TCGA-25-1320-01A
65 years, female, white, stage:Stage IIIC, dead, 1155 days
2735.2
TCGA-24-1843-01A
66 years, female, white, stage:Stage IIIC, alive, 106 days
2734.8
TCGA-25-2400-01A
76 years, female, white, stage:Stage IIIC, dead, 1278 days
2734.2
TCGA-25-2042-01A
60 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
2726.5
TCGA-25-1633-01A
64 years, female, white, stage:Stage IIIC, dead, 1891 days
2720.8
TCGA-61-1733-01A
71 years, female, white, stage:Stage IIIC, alive, 967 days
2710.0
TCGA-04-1514-01A
45 years, female, white, stage:Stage IIIA, dead, 1720 days
2700.8
TCGA-25-2404-01A
38 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
2700.3
TCGA-24-1565-01A
74 years, female, white, stage:Stage IIIC, dead, 312 days
2695.5
TCGA-61-1724-01A
47 years, female, white, stage:Stage IIIC, dead, 637 days
2650.1
TCGA-29-2428-01A
58 years, female, white, stage:Stage IIIC, alive, 1372 days
2638.7
TCGA-24-2254-01A
66 years, female, white, stage:Stage IIIC, dead, 1736 days
2601.7
TCGA-24-1603-01A
53 years, female, white, stage:Stage IIIB, dead, 2742 days
2597.7
TCGA-29-1781-01A
69 years, female, white, stage:Stage IIIC, alive, 255 days
2577.0
TCGA-36-1568-01A
52 years, female, stage:Stage IIIC, alive, 875 days
2499.2
TCGA-31-1953-01A
52 years, female, asian, stage:Stage IIIC, alive, 204 days
2493.9
TCGA-09-2051-01A
42 years, female, white, stage:Stage IIIC, alive, 1919 days
2452.8
TCGA-29-1693-01A
72 years, female, white, stage:Stage IIIC, alive, 3096 days
2418.0
TCGA-57-1994-01A
63 years, female, white, stage:'--, alive, 761 days
2369.5
TCGA-24-2288-01A
70 years, female, white, stage:Stage IIIC, dead, 25 days
2342.7
TCGA-24-1424-01A
67 years, female, white, stage:Stage IIIC, alive, 183 days
2328.2
TCGA-24-2026-01A
79 years, female, white, stage:Stage IIIC, dead, 1059 days
2323.7
TCGA-24-2036-01A
50 years, female, white, stage:Stage IIIA, dead, 1947 days
2321.9
TCGA-61-2102-01A
74 years, female, white, stage:Stage IIIC, dead, 197 days
2302.9
TCGA-25-1626-01A
65 years, female, white, stage:Stage IIIC, dead, 518 days
2274.8
TCGA-24-1844-01A
64 years, female, white, stage:Stage IIIC, alive, 113 days
2274.0
TCGA-25-1635-01A
71 years, female, white, stage:Stage IIIC, dead, 1583 days
2238.7
TCGA-31-1959-01A
49 years, female, white, stage:Stage IV, alive, 67 days
2229.1
TCGA-36-1574-01A
48 years, female, asian, stage:Stage IIIC, alive, 686 days
2207.3
TCGA-61-2012-01A
81 years, female, white, stage:Stage IIC, alive, 932 days
2154.7
TCGA-57-1993-01A
56 years, female, white, stage:Stage IIIC, alive, 763 days
2149.3
TCGA-24-2271-01A
55 years, female, asian, stage:Stage IIIC, dead, 962 days
2127.6
TCGA-61-2088-01A
51 years, female, white, stage:Stage IIIC, alive, 145 days
2080.2
TCGA-24-1847-01A
45 years, female, white, stage:Stage IV, alive, 343 days
2062.4
TCGA-36-1581-01A
63 years, female, white, stage:Stage IIC, alive, 751 days
2061.5
TCGA-09-0366-01A
55 years, female, white, stage:Stage IIIC, dead, 1757 days
2057.1
TCGA-24-2297-01A
56 years, female, white, stage:Stage IIIC, dead, 1699 days
2057.0
TCGA-29-1774-01A
82 years, female, white, stage:Stage IIIC, alive, 527 days
2039.9
TCGA-29-1710-01A
54 years, female, white, stage:Stage IIIC, dead, 951 days
2008.4
TCGA-09-2045-01A
50 years, female, asian, stage:Stage IV, dead, 1069 days
1962.3
TCGA-24-1427-01A
58 years, female, stage:Stage IIIC, alive, 147 days
1873.3
TCGA-61-2113-01A
53 years, female, white, stage:Stage IIC, dead, 676 days
1853.2
TCGA-59-2348-01A
59 years, female, white, stage:Stage IIIC, alive, 5481 days
1852.0
TCGA-29-1711-01A
45 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
1773.6
TCGA-24-2261-01A
76 years, female, white, stage:Stage IIIC, dead, 24 days
1745.7
TCGA-20-1683-01A
65 years, female, white, stage:Stage IIIC, alive, 772 days
1683.9
TCGA-61-2104-01A
53 years, female, white, stage:Stage IIC, alive, 2338 days
1557.6
TCGA-24-1557-01A
49 years, female, white, stage:Stage IIIC, dead, 1213 days
1555.2
TCGA-24-1928-01A
77 years, female, white, stage:Stage IIIC, dead, 336 days
1471.9
TCGA-25-1319-01A
73 years, female, white, stage:Stage IIIC, dead, 1977 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPS20 is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the pTPM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (pTPM) was examined. The best expression cut-off refers the pTPM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average pTPM
3651.1
Number of samples
81
Samples
Sample
Description
pTPM
DO46394
61 years, female, NA, stage:IV, dead, 1039 days
22483.1
DO46356
68 years, female, NA, stage:III, dead, 911 days
13287.9
DO46588
74 years, female, NA, stage:III, dead, 438 days
9156.2
DO46331
72 years, female, NA, stage:III, dead, 612 days
8106.1
DO46390
65 years, female, NA, stage:III, dead, 374 days
7820.4
DO46338
59 years, female, NA, stage:III, dead, 596 days
6759.6
DO46333
58 years, female, NA, stage:III, dead, 359 days
6219.9
DO46523
52 years, female, NA, stage:IV, alive, 1873 days
5528.0
DO46360
58 years, female, NA, stage:IV, dead, 1759 days
5387.0
DO46463
49 years, female, NA, stage:III, dead, 2451 days
5370.3
DO46402
77 years, female, NA, stage:III, dead, 511 days
5249.0
DO46576
75 years, female, NA, stage:III, alive, 133 days
4950.1
DO46384
55 years, female, NA, stage:III, dead, 614 days
4641.1
DO46366
65 years, female, NA, stage:III, dead, 2054 days
4613.6
DO46342
67 years, female, NA, stage:III, dead, 1398 days
4571.2
DO46586
55 years, female, NA, stage:III, dead, 1019 days
4536.9
DO46591
58 years, female, NA, stage:III, dead, 195 days
4491.4
DO46518
62 years, female, NA, stage:III, alive, 2960 days
4463.3
DO46551
58 years, female, NA, stage:III, dead, 1055 days
4274.3
DO46611
52 years, female, NA, stage:III, dead, 734 days
4190.4
DO46546
73 years, female, NA, stage:III, dead, 1889 days
4075.9
DO46561
52 years, female, NA, stage:III, dead, 195 days
4068.8
DO46581
66 years, female, NA, stage:III, dead, 408 days
4004.8
DO46443
59 years, female, NA, stage:III, dead, 2464 days
3954.2
DO46568
66 years, female, NA, stage:III, dead, 320 days
3925.0
DO46400
70 years, female, NA, stage:III, dead, 719 days
3894.3
DO46438
55 years, female, NA, stage:IV, alive, 2227 days
3840.5
DO46346
54 years, female, NA, stage:III, dead, 1187 days
3728.2
DO46398
66 years, female, NA, stage:III, alive, 437 days
3718.1
DO46453
66 years, female, NA, stage:III, dead, 3294 days
3672.6
DO46326
51 years, female, NA, stage:III, dead, 701 days
3608.9
DO46597
60 years, female, NA, stage:III, dead, 393 days
3236.3
DO46334
77 years, female, NA, stage:III, dead, 496 days
3226.3
DO46370
54 years, female, NA, stage:III, dead, 1727 days
3174.6
DO46328
52 years, female, NA, stage:III, dead, 972 days
3171.1
DO46348
58 years, female, NA, stage:IV, dead, 287 days
3095.6
DO46606
73 years, female, NA, stage:III, alive, 804 days
3089.1
DO46388
74 years, female, NA, stage:III, dead, 413 days
3081.3
DO46340
62 years, female, NA, stage:III, dead, 616 days
3069.3
DO46566
78 years, female, NA, stage:III, dead, 673 days
3032.7
DO46364
45 years, female, NA, stage:III, dead, 806 days
3020.0
DO46533
46 years, female, NA, stage:III, alive, 3667 days
3006.2
DO46392
48 years, female, NA, stage:III, dead, 628 days
2998.6
DO46408
56 years, female, NA, stage:III, dead, 489 days
2934.7
DO46538
57 years, female, NA, stage:III, dead, 1527 days
2765.9
DO46330
60 years, female, NA, stage:III, dead, 684 days
2744.3
DO46327
54 years, female, NA, stage:III, dead, 184 days
2698.7
DO46448
45 years, female, NA, stage:III, dead, 654 days
2583.1
DO46358
60 years, female, NA, stage:III, dead, 423 days
2566.6
DO46376
58 years, female, NA, stage:III, dead, 1430 days
2557.7
DO46352
60 years, female, NA, stage:III, dead, 677 days
2510.8
DO46374
69 years, female, NA, stage:III, dead, 1409 days
2443.2
DO46404
55 years, female, NA, stage:III, dead, 690 days
2436.9
DO46380
51 years, female, NA, stage:III, dead, 1423 days
2432.1
DO46336
70 years, female, NA, stage:IV, dead, 664 days
2286.0
DO46368
57 years, female, NA, stage:III, dead, 2879 days
2281.0
DO46396
64 years, female, NA, stage:III, dead, 583 days
2221.5
DO46508
50 years, female, NA, stage:III, dead, 2101 days
2209.9
DO46560
45 years, female, NA, stage:IV, dead, 286 days
2174.7
DO46513
54 years, female, NA, stage:IV, dead, 1883 days
2163.7
DO46362
61 years, female, NA, stage:III, dead, 1639 days
2095.7
DO46528
56 years, female, NA, stage:III, alive, 6139 days
2072.4
DO46382
62 years, female, NA, stage:IV, dead, 311 days
2064.9
DO46412
64 years, female, NA, stage:III, dead, 597 days
1944.0
DO46350
66 years, female, NA, stage:III, dead, 886 days
1938.9
DO46378
59 years, female, NA, stage:III, alive, 843 days
1920.6
DO46386
49 years, female, NA, stage:III, dead, 1162 days
1904.6
DO46354
73 years, female, NA, stage:III, dead, 843 days
1864.4
DO46428
59 years, female, NA, stage:IV, alive, 2644 days
1846.6
DO46602
74 years, female, NA, stage:III, dead, 205 days
1837.9
DO46325
54 years, female, NA, stage:III, dead, 477 days
1809.8
DO46493
62 years, female, NA, stage:IV, alive, 839 days
1787.5
DO46571
61 years, female, NA, stage:III, dead, 243 days
1728.2
DO46432
56 years, female, NA, stage:III, alive, 2218 days
1724.9
DO46436
58 years, female, NA, stage:III, alive, 3193 days
1709.5
DO46344
46 years, female, NA, stage:III, dead, 642 days
1708.9
DO46468
67 years, female, NA, stage:III, alive, 2776 days
1663.1
DO46329
52 years, female, NA, stage:III, dead, 1699 days
1619.5
DO46332
56 years, female, NA, stage:III, dead, 689 days
1593.1
DO46372
39 years, female, NA, stage:III, dead, 1326 days
1572.2
DO46458
67 years, female, NA, stage:IV, alive, 3787 days
1537.5
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
1.0
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
0.9
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
0.9
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
0.9
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
0.9
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
0.8
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
0.8
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
0.7
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
0.7
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
0.7
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
0.6
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
0.6
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
0.6
1a10c200-3895-4648-b951-94f99f_D2
Tumor
0.6
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
0.6
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
0.6
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
0.6
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
0.6
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
0.6
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
0.6
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
0.6
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
0.5
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
0.5
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
0.5
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
0.5
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
0.5
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
0.5
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
0.5
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
0.5
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
0.5
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
0.5
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
0.5
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
0.4
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
0.4
161317f3-1a39-438e-af45-cd2502_D2
Tumor
0.4
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
0.4
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
0.4
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
0.4
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
0.4
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
0.4
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
0.4
2f901c90-617e-46da-9fac-d68369_D2
Tumor
0.4
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
0.4
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
0.4
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
0.3
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
0.3
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
0.3
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
0.3
285fed94-1495-448e-879b-b55de9_D2
Tumor
0.3
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
0.3
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
0.3
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
0.2
1772e913-f62e-446a-8cf3-720348_D2
Tumor
0.2
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
0.2
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
0.2
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
0.1
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
0.1
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
0.1
340a3769-3031-41ae-bb08-a2f696_D2
Normal
0.1
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
0.1
e9d416e7-f661-400a-896e-388545_D2
Tumor
0.1
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
0.1
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
0.1
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
0.1
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
0.1
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
0.0
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
0.0
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
0.0
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
0.0
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
0.0
15524912-685a-47ce-a824-567848_D2
Tumor
-0.1
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
-0.1
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
-0.1
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
-0.1
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
-0.1
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
-0.1
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
-0.1
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
-0.2
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
-0.2
10c2d629-0287-4511-ac25-f29031_D2
Tumor
-0.2
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
-0.2
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
-0.2
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
-0.3
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
-0.3
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
-0.3
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
-0.3
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
-0.4
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
-0.4
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
-0.4
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
-0.4
a65d8e76-640f-4341-a561-afbb57_D2
Normal
-0.4
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
-0.5
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
-0.5
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
-0.5
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-0.5
a3a26070-fb84-406a-8280-d555e6_D2
Normal
-0.5
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
-0.5
1db5574d-aca7-403c-8100-6e705f_D2
Normal
-0.5
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
-0.5
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
-0.5
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
-0.6
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
-0.6
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
-0.8
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
-0.8
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
-0.8
21efd60f-6a31-4b98-9477-16a905_D2
Normal
-0.9
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
-1.0
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
-1.3
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.
Ascending and descending describe two types of gradient, based on difference in staining intensity between enterocytes in crypts and apical enterocytes.
Ascending - the staining intensity is stronger in apical enterocytes (towards the lumen) compared to enterocytes in the crypts (gland based)
Descending - the staining is weaker in apical enterocytes compared to enterocytes in crypts